FMP
NASDAQ
4.11 USD
0.22 (5.35%)
Dr. Mihael H. Polymeropoulos M.D.
Healthcare
Biotechnology
https://www.vandapharma.com
NASDAQ
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule ...
0001347178
US9216591084
921659108
2200 Pennsylvania Avenue NW
202 734 3400
US
203
Apr 12, 2006
0001347178
NASDAQ
Biotechnology
Healthcare
921659108
US9216591084
US
4.11
0.77
976.4k
236.48M
-
3.3-7.0
11.22
-
-
-
-
102.75
-
https://www.vandapharma.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.